NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 4 percent year over year increase in its fiscal second quarter revenues on record performance in its diagnostics and life science segments.
For the three months ended March 31, the Cincinnati-based company's revenues rose to $56.5 million from $54.1 million a year ago, surpassing analysts' consensus estimate of $55.0 million.